levormeloxifene has been researched along with Uterine Prolapse in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christiansen, C; Christoffersen, C; Delmas, PD; Riis, BJ; Stakkestad, JA; Warming, L | 1 |
1 trial(s) available for levormeloxifene and Uterine Prolapse
Article | Year |
---|---|
Adverse effects of a SERM (Levormeloxifene). Safety parameters and bone mineral density 12 months after treatment withdrawal.
Topics: Bone Density; Double-Blind Method; Endometrium; Female; Follow-Up Studies; Humans; Middle Aged; Pyrrolidines; Receptors, Estrogen; Safety; Selective Estrogen Receptor Modulators; Substance Withdrawal Syndrome; Time Factors; Urinary Incontinence; Uterine Prolapse | 2003 |